Atypical Localized Scleroderma Development During Nivolumab Therapy for Metastatic Lung Adenocarcinoma. Fixsen E, Patel J, Kheterpal M. Cutis 2022;110:E11-E13.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fixsen E, Patel J, Kheterpal M. Atypical Localized Scleroderma Development During Nivolumab Therapy for Metastatic Lung Adenocarcinoma. Cutis 2022;110:E11-E13.
PMID: 36446107